Non small cell lung cancer;Cancer bronchique non à petites cellules

Cancer/Radiotherapie

Volumn 14, Issue SUPPL. 1, 2010, Pages

  Leignel Argo, D ^a   Giraud, P ^b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Atlas; Conformal radiotherapy; Non small cell lung cancer; Target volumes

Indexed keywords

ARTICLE; CANCER LOCALIZATION; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; HUMAN; IRRADIATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; MEDICAL LITERATURE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; THORAX; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG; LUNG NEOPLASMS; NEOPLASM STAGING; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL;

EID: 78649800916     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(10)70009-3     Document Type: Article

References (48)

1. Ahn S.J., Kahn D., Zhou S., Yu X., Hollis D., Shafman T.D., et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 2005, 61:335-347.
2. Armstrong J.G., Burman C., Leibel S., Fontenla D., Kutcher G., Zelefsky M., et al. Three dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 1993, 26:685-689.
3. Arpin D., Mahé M.A., Servois V., Claude L. Facteurs prédictifs de la pneumopathie radique aiguë. Rev Pneumol Clin 2009, 65:177-186.
4. Carrasco P., Jornet N., Duch M.A., Weber L., Ginjaume M., Eudaldo T., et al. Comparison of dose calculation algorithms in phantoms with lung equivalent heterogeneities under conditions of lateral electronic disequilibrium. Med Phys 2004, 31:2899-2911.
5. Chapet O. Complications aiguës et tardives des irradiations thoraciques. Cancer Radiother 2007, 11:92-100.
6. Chapet O., Kong F.M., Quint L.E., Chang A.C., Ten Haken R.K., Eisbruch A., et al. CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 2005, 63:170-178.
7. Cox J.D., Stetz J.A., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 2005, 62:988-994.
8. De Ruysscher D., Wanders S., Van Haren E., Hochstenbag M., Geeraedts W., Utama I., et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 2005, 62:988-994.
9. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
10. Emami B., Mirkovic N., Scott C., Byhardt R., Graham M.V., James Andras E., et al. The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data. Lung Cancer 2003, 41:207-214.
11. Giraud P., Antoine M., Larrouy A., Milleron B., Callard P., De Rycke Y., et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000, 48:1015-1024.
12. Giraud P., Cosset J.M. Toxicité cardiaque de la radiothérapie:physiopathologie, données cliniques. Bull cancer 2004, 91:S147-S153.
13. Giraud P. Influence of CT images visualization parameters for target volume delineation in lung cancer. Radiother Oncol 2000, 56(suppl 1):S39.
14. Giraud P., Yorke E., Jiang S.B., Simon L., Rosenzweig K., Mageras G. Reduction of organ motion effects in IMRT and conformal 3D radiation delivery by using gating and tracking techniques. Cancer Radiother 2006, 10:269-282.
15. Graham M.V., Purdy J.A., Emami B., Harms W., Bosch W., Lockett M.A., et al. Clinical dose volume histograms analysis for pneumonitis after 3D treatment for non small cell lung cancer. Int J Radiat Oncol Biol Phys 1999, 45:323-329.
16. Grills I.S., Fitch D.L., Goldstein N.S., Yan D., Chmielewski G.W., Welsh R.J., et al. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: Defining clinical target volume for radiotherapy. Int J Radiation Oncology Biol Phys 2007, 69:334-341.
17. Cancer Radiother 2008, 12:143-313. Guide des procédures de radiothérapie externe 2007.
18. Guide ALD Guide ALD 30 « Cancer du poumon et mésothéliome pleural » INCa/HAS. 2009. Téléchargeable: http://www.has-sante.fr%20et%20sur%20http%3a//www.e-cancer.fr.
19. International Commission on Radiation Units and Measurments. Prescribing, recording and reporting photon beam therapy. Washington 1993 and 1999. Int J Radiat Oncol Biol Phys 2009, 73:1602. ICRU 50 and ICRU 62 reports.
20. Jeremic B. Incidental irradiation of nodal regions at risk during limited field radiotherapy in dose escalation studies in non small cell lung cancer (NSCLC). Enough to convert no-elective to elective nodal irradiation (ENI)?. Radiother Oncol 2004, 71:123-125.
21. Kim T.H., Cho K.H., Pyo H.R., Lee J.S., Han J.Y., Zo J., et al. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2005, 62:995-1002.
22. Machtay M., Lee J.H., Shrager J.B., Kaiser L.R., Glatstein E. Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high risk resected non-small-cell lung carcinoma. J Clin Oncol 2001, 19:3912-3917.
23. Mackillop W.J., Bates J.H.T., O'Sullivan B., Withers H.R. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys 1996, 34:243-250.
24. Mah K., Caldwell C.B., Ung Y.C., Danjoux C.E., Balogh J.M., Ganguli S.N., et al. The impact of 18FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study. Int J Radiat Oncol Biol Phys 2002, 52:339-350.
25. Martel-Lafay I., Fourneret P., Ayadi M., Brun O., Buatois F., Carrie C., et al. Guide de bonne pratique pour la radiothérapie thoracique exclusive ou postopératoire des carcinomes non à petites cellules. Cancer Radiother 2009, 13:55-60.
26. Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest 1997, 111:1718-1723.
27. Movsas B., Raffin T.A., Epstein A.H., Link C.J. Pulmonary radiation injury. Chest 1997, 111:1061-1076.
28. Murray C.J., Lopez A.D. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997, 349:1269-1276.
29. Nohl-Oser H.C. An investigation of the anatomy of the lymphatic drainage of the lungs. Ann Roy Coll Surg Engl 1972, 51:157-176.
30. Patel A.B., Edelman M.J., Kwok Y., Krasna M.J., Suntharalingam M. Predictors of acute esophagitis in patients with non-small cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2004, 60:1106-1112.
31. Post operative radiotherapy for non-small cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet 1998, 352:257-263. PORT Meta-analysis Trialists Group.
32. Prosnitz R.G., Chen Y.H., Marks L.B. Cardiac toxicity following thoracic radiation. Sem Oncol 2005, 32:S71-S80.
33. Rancati T., Ceresoli G.L., Gagliardi G., Schipani S., Cattaneo G.M. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 2003, 67:275-283.
34. Rapport et Synthèse INCa:La situation du cancer en France en 2009. 2009. Téléchargeable: http://www.e-cancer.fr/.
35. Recommandations INCa pour la prise en charge thérapeutique des formes inopérables du cancer du poumon non à petites cellules. 2009. Téléchargeable: http://www.e-cancer.fr/.
36. Riquet M. Cancer bronchique:le drainage lymphatique. Cancer Radiother 2007, 11:4-10.
37. Rosenzweig K.E., Sim S.E., Mychalczak B., Braban L.E., Schindelheim R., Leibel S.A. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2001, 50:681-685.
38. Saunders M., Dische S., Barrett A., Harvey A., Gibson D., Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: a randomized multicenter trial. CHART Steering Committee. Lancet 1997, 350:161-165.
39. Senan S., De Ruysscher D., Giraud P., Mirimanoff R., Budach V. Literature based recommendations for treatment planning and execution in highdose radiotherapy for lung cancer. Radiother Oncol 2004, 71:139-146.
40. Seppenwoolde Y., Lebesque J.V., De Jaeger K., Belderbos J.S.A., Boersma L.J., Schilstra C., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 2003, 55:724-735.
41. Trotti A., Colevas A.D., Setser A., Rusch V., Jaques D., Budach V., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003, 13:176-181.
42. Van Sornsen de Koste J.R., Lagerwaard F.J., Nijssen-Visser M.R.J., Schuchhard-Schipper R., Joosten H., Senan S. What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer?. Int J Radiat Oncol Biol Phys 2002, 53:1211-1215.
43. Vanuytsel L., Vansteenkiste J.F., Stroobants S.G., De Leyn P.R., De Wever W., Verbeken E.K., et al. The impact of 18 F-fluoro-2-deoxy-D-glucose positron emission tomography (FDGPET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 2000, 55:317-324.
44. Vaylet F., Bonnichon A., Salles Y., Gontier E., Bonardel G., Lefloch H., et al. La tomographie par émission de positons au 18-fluorodésoxyglucose (18FDG-TEP) dans la prise en charge du cancer bronchique non à petites cellules en 2006. Cancer Radiother 2007, 11:16-22.
45. Vijayakumar S., Myrianthopoulos L.C., Rosenberg I., Halpern H.J., Low N., Chen G.T., et al. Optimization of radical radiotherapy with beam's eye view techniques for non-samll cell lung cancer. Int J Radiat Oncol Biol Phys 1991, 21:779-788.
46. Yorke E.D., Jackson A., Rosenzweig K.E., Braban L., Leibel S.A., Ling C.C. Correlation of dosimetric factors and radiation pneumonitis for nonsmall cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 2005, 63:672-682.
47. Yuan S., Sun X., Li M., Yu J., Ren R., Yu Y., et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 2007, 30:239-244.
48. Gérard JP, Ortholan C, Pointreau Y (eds). Dose de tolérance à l'irradiation des tissus sains. Cancer radiother 2010; 14(4-5):227-40.